Colgate-Palmolive's US toothpaste business has been a persistent drag on the company's results, but analysts at RBC Capital Markets believe the worst may soon be over. In a recent note, RBC said the US segment could stabilize by the first quarter of 2027, as the company cycles past what it called “self-inflicted” mistakes and as market share losses begin to slow.
For everyday investors, this is a signal that one of the company's biggest headaches might finally be easing. But the path to a full recovery is not guaranteed, and RBC suggests that a stronger comeback may require more aggressive steps, such as launching an entirely new brand.
A tale of two businesses
Colgate-Palmolive, best known for its toothpaste and oral care products, has seen its performance diverge sharply by region. According to RBC, the company's international operations have continued to deliver solid growth, with organic sales rising in the mid-to-high single digits. Organic growth strips out the effects of currency fluctuations and major acquisitions, giving a clearer picture of underlying demand.
Meanwhile, the US segment has been a weak spot, with negative organic sales. That means Americans are buying less Colgate toothpaste than they did a year earlier, even before accounting for price changes or currency effects. The decline has weighed on the company's overall results and frustrated investors who watch the US market as a key profit driver.
RBC attributes part of the problem to “self-inflicted” mistakes. While the note does not detail every misstep, such issues often include pricing decisions that alienate shoppers, product innovation that misses the mark, or marketing campaigns that fail to resonate. In a competitive category like toothpaste, where brands like Crest and Sensodyne are constantly vying for shelf space, even small errors can lead to noticeable share losses.
Why stabilization matters
For Colgate, stabilizing the US business is crucial. The US is one of the world's largest consumer markets, and toothpaste is a staple purchase for most households. When a company loses share in such a core category, it can take years to win back consumers, especially if competitors have gained momentum.
RBC's forecast that the decline could level off in Q1 2027 suggests that the company is nearing the end of a difficult cycle. By that point, Colgate will have cycled past the period when its mistakes were most damaging, and the year-over-year comparisons will become easier. In other words, even if sales remain flat, they will no longer be falling, which would be a meaningful improvement.
However, RBC cautions that a stronger comeback may require tougher moves. One option mentioned is launching a new brand. In the consumer goods world, a fresh brand can reinvigorate a category and attract younger or more health-conscious shoppers who may have drifted to competitors. But new brands are risky and expensive to build, and there is no guarantee of success.
What it means for investors
For investors, the key takeaway is that Colgate's US problems are not permanent, but they are also not resolving quickly. The company's international strength provides a cushion, but the US drag will likely continue to pressure earnings for at least another year or two.
Investors should watch for signs that the company is taking bolder steps, such as a new brand launch or a major marketing push. They should also monitor quarterly results for any early signs that US organic sales are improving, even if they remain negative.
It's also worth noting that Colgate's situation is not unique. Many consumer staples companies have struggled with sluggish US growth as shoppers become more price-sensitive and competition intensifies. The broader economic backdrop, including small business optimism slipping and cost pressures squeezing margins, can affect consumer spending habits. While these are not direct drivers for Colgate, they reflect the challenging environment for companies selling everyday goods.
RBC's note is a reminder that even large, established companies can stumble, but with time and strategic adjustments, they can often recover. For Colgate, the next few quarters will be critical in determining whether the US business truly stabilizes or if more drastic measures are needed.
As always, investors should consider their own financial goals and risk tolerance before making any decisions. This analysis is meant to explain the news, not to recommend a specific course of action.
